Literature DB >> 4027148

The acute haemodynamic effects of oral nicardipine.

R M McCredie, W B McKenzie, D A McGill.   

Abstract

The haemodynamic effects of oral nicardipine at two different doses were assessed in fifteen patients at rest following diagnostic cardiac catheterisation. Six patients received four doses of 20 mg nicardipine hydrochloride orally every 8 h, and nine patients received four doses of 30 mg orally every 8 h. No side effects were encountered with either dose. At both dose levels, there was a significant fall in systemic vascular resistance, significant increases in heart rate and cardiac output, and no change in stroke volume index. No changes were seen in pulmonary vascular haemodynamics, and there were no significant changes in mean arterial pressure. Plasma levels of nicardipine reached a peak within 1 h. In parallel with the haemodynamic effects, the plasma concentrations achieved after the third and fourth doses were higher than after the first dose. These haemodynamic changes are consistent with a vasodilator effect, which produces a decrease in peripheral vascular resistance. It would appear that the 30 mg dose has a more potent vasodilator action than the 20 mg dose and, in the patients studied, this larger dose was not associated with any side effects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027148      PMCID: PMC1400766          DOI: 10.1111/j.1365-2125.1985.tb05160.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Comparison of acute effects of nifedipine in normotensive and hypertensive man.

Authors:  O Lederballe Pedersen; N J Christensen; K D Rämsch
Journal:  J Cardiovasc Pharmacol       Date:  1980 Jul-Aug       Impact factor: 3.105

2.  Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine.

Authors:  A Iliopoulou; P Turner; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

3.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

4.  Effect of nifedipine (Adalat) on coronary haemodynamics in patients with coronary arteriosclerotic disease.

Authors:  S Simonsen; S Nitter-Hauge
Journal:  Acta Med Scand       Date:  1978

5.  The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.

Authors:  R I Jones; R S Hornung; T Sonecha; E B Raftery
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

6.  Influence of nicardipine on the blood pressure at rest and on the pressor responses to cold, isometric exertion, and dynamic exercise in hypertensive patients.

Authors:  S H Taylor; B Silke; R C Ahuja; R Okoli
Journal:  J Cardiovasc Pharmacol       Date:  1982 Sep-Oct       Impact factor: 3.105

  6 in total
  3 in total

Review 1.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Nicardipine HCl: clinical experience in patients undergoing anaesthesia for intracranial aneurysm clipping.

Authors:  D S Warner; M D Sokoll; M Maktabi; J C Godersky; H P Adams
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

Review 3.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.